Effect of Release of Upper Track of Deep Front Facial Line Versus Myofascial Release With IASTM on Patients With Upper Cross Syndrome
UCS
1 other identifier
interventional
90
1 country
1
Brief Summary
this study will be conducted to compare the effect of release of upper track of deep front facial line versus myofascial release with IASTM on patients with Upper Cross Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedFebruary 12, 2026
February 1, 2026
10 months
March 26, 2025
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
neck disability
The neck disability assessment will be performed using the Neck Disability Index (NDI) questionnaire - it contains ten items that refer to neck pain (intensity) and the level of ability to manage daily living activities (personal care, reading, lifting, headache, work, concentration, driving, sleep and recreation). The NDI score is interpreted as 0-4=no disability, 5-14=mild disability, 15-24=moderate disability, 25-34=severe disability, and over 34= total disability, where a score of 50 converted to percentiles represents 100%. NDI score is calculated as follows: total score/total possible score, transformed to percentage multiplied by 100=% points
up to four weeks
Secondary Outcomes (6)
pain intensity
up to four weeks
craniovertebral angle
up to four weeks
kyphosis angle
up to four weeks
upper chest expansion
up to four weeks
lower chest expansion
up to four weeks
- +1 more secondary outcomes
Study Arms (3)
Upper Track of Deep Front Facial Line realese
EXPERIMENTALThirty subjects received release of upper track of deep front facial line in addition supervised corrective exercises three times a week for four weeks.
Myofascial Release With IASTM
EXPERIMENTALthirty subjects received myofascial release with IASTM in addition supervised corrective exercises three time a week for four weeks
supervised corrective exercises
ACTIVE COMPARATORthirty subjects received supervised corrective exercises three time a week for four weeks
Interventions
The MFR techniques were applied to the designated regions, with soft, steady pressure lasting 90 to 120 seconds postural correction exercises The upper track of deep front facial line release procedures were applied. Hyoid mobilization; Larynx mobilization; Sternal oscillations; and Barral's Transversus Thoracis mobilization. The thoracic inlet releasing ; intrathoracic fascia elongation; scalene releasing and diaphragm relaxation
The instrument is designed to mobilize soft tissues. Facilitation approaches were employed to break apart adhesions. Emollient Gel/Lubrication Gel (Hawk Grips product) was also used to lubricate the skin and allow the instrument to move more easily. The tool has two sides: one for therapy and the other for holding plus postural correction exercises
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
Eligibility Criteria
You may qualify if:
- Age between 18-40 years old
- All participants had forward head, craniovertebral angle \< 50.
- All participants had rounded back (kyphosis angle ≥ 42°)
- Based on assessment of upper cross syndrome by photogrammetric analysis.
- The subjects were chosen from both genders.
You may not qualify if:
- History of trauma or surgery in cervical region.
- Bone fractures or acute soft tissue injuries.
- Osteoporosis.
- Heart attack.
- Unstable angina pectoris -Implanted pacemaker or defibrillator- -Cancer-
- Rheumatoid arthritis
- Connective tissue disease: This includes diseases such as osteomyelitis, lupus and scleroderma -Neurological conditions-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Alshaymaa Shaaban Abdelazeim
Giza, Dokki, 11351, Egypt
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- opaque sealed envelope
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator : alshaymaa shaaban abd el azeim
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 2, 2025
Study Start
April 1, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
February 12, 2026
Record last verified: 2026-02